MENU
BLSM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BlossomHill Therapeutics (BLSM) Earnings Date & Reports
BlossomHill Therapeutics Inc is a clinical-stage biopharmaceutical company applying its intentional, chemistry-based approach to develop small molecule medicines that address unmet medical needs in cancer treatment... Show more
A.I. Advisor
published Earnings
BLSM is expected to report earnings to fall 89.37% to -93 cents per share on December 18
Q3'26
Est.
$-0.93
Q2'26
Missed
by $7.91
The last earnings report on September 18 showed earnings per share of -875 cents, missing the estimate of -83 cents. With 39.65K shares outstanding, the current market capitalization sits at 483.45M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
10255 Science Center Drive
Phone
+1 858 732-3880
Employees
63
Web
https://www.bhtherapeutics.com